A61K 39/36
From pollen
Official title: from pollen
A61K39/36 (From pollen) appears on 155 US grants and 266 published applications in this corpus.
Search patents in A61K- Granted patents
- 155
- Published applications
- 266
- Assignees
- 131
- Inventors
- 458
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 5 |
| 2003 | 3 | 6 |
| 2004 | 0 | 4 |
| 2005 | 0 | 6 |
| 2006 | 3 | 9 |
| 2007 | 3 | 8 |
| 2008 | 1 | 5 |
| 2009 | 7 | 10 |
| 2010 | 2 | 13 |
| 2011 | 3 | 9 |
| 2012 | 3 | 25 |
| 2013 | 12 | 16 |
| 2014 | 8 | 20 |
| 2015 | 8 | 20 |
| 2016 | 16 | 20 |
| 2017 | 11 | 14 |
| 2018 | 13 | 9 |
| 2019 | 6 | 5 |
| 2020 | 3 | 9 |
| 2021 | 4 | 6 |
| 2022 | 5 | 13 |
| 2023 | 4 | 8 |
| 2024 | 3 | 13 |
| 2025 | 3 | 8 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist18 Aug 2026US 12,708,666 B2Regeneron Pharmaceuticals, Inc.
- Method of modulating mucosal immunogenicity31 Mar 2026US 12,589,149 B2Advagene Biopharma Co., Ltd.
- Allergen desensitization method24 Feb 2026US 12,558,419 B2Assistance Publique-Hopitaux de Paris
- System and method for controlling the humidity and pressure in a luminaire25 Nov 2025US 12,480,651 B2Robe Lighting s.r.o.
- Allergen desensitization method2 Sep 2025US 12,403,193 B2Assistance Publique-Hopitaux de Paris
- Recombinant artemisia vulgaris pollen group 3 allergen, and preparation method therefor and use thereof30 Jul 2026US 2026/0216322 A1Zonhonbiopharma Institute Inc.
- Allergen desensitization method23 Apr 2026US 2026/0108598 A1Assistance Publique-Hopitaux de Paris
- Methods, compositions and therapeutical vaccine for autoimmune diseases and allergy treatment16 Apr 2026US 2026/0102482 A1
- Thermosensitive hydrogel composition9 Apr 2026US 2026/0096983 A1Desentum Oy
- Sublingual tablet and application thereof in desensitization therapy drug29 Jan 2026US 2026/0027044 A1Zonhon Biopharma Institute Inc.
Most cited
By later US patents
- Immunostimulatory polynucleotide/immunomodulatory molecule conjugates162US 6,610,661 B1The Regents of the University of California · 2003
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- Immunostimulatory polynucleotide/immunomodulatory molecule conjugates97US 7,208,478 B2The Regents of the University of California · 2007
- Allergen-containing substances87US 4,261,973 APharmacia Corporation · 1981
- Oral administration of immunologically active biomolecules and other therapeutic proteins55US 5,591,433 AUniversity of Cincinnati · 1997